Pancreatic Adenocarcinoma — Trials

Pancreatic Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 357
Recruiting: 209
Ph III recruiting: 23
Growth YoY: +36.1%
Industry share: 41%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

clinicaltrialsPublishedShowing 901–916 of 916 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01401387	Pancreatic Enzyme Suppletion in Pancreatic Cancer(EPC)	withdrawn	Phase 4	0	Foundation for Liver ResearchOTHER	1	Feb 22, 2013	clinicaltrials
NCT00028496	Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer	completed	Phase 1	48	National Cancer Institute (NCI)NIH	1	Jan 25, 2013	clinicaltrials